Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Pain 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lymphoma 1Leukemia 1

Interventions

Cyclophosphamide 38fludarabine phosphate 34Peripheral Blood Stem Cell Transplantation 28Busulfan 26Tacrolimus 22Antilymphocyte Serum 22Mycophenolic Acid 21Filgrastim 20Cyclosporine 20Radiotherapy 17Methotrexate 16Melphalan 14Whole-Body Irradiation 12Etoposide 12Methylprednisolone 11Cord Blood Stem Cell Transplantation 11Cytarabine 8Sirolimus 7Alemtuzumab 7Psychiatric Rehabilitation 6Flow Cytometry 6Cyclosporins 6Thiotepa 5Rituximab 5Polymerase Chain Reaction 4Early Intervention, Educational 4sargramostim 3Immunologic Techniques 3Immunoenzyme Techniques 3Granulocyte Colony-Stimulating Factor 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myelodysplastic-Myeloproliferative Diseases × Baclofen × Lymphoid × Clear all
NCT00516503 2017-08-24

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
208 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Pain, Neurotoxicity Syndromes, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡